A case series describing the epidemiology and clinical characteristics of COVID-19 infection in Jilin Province

ABSTRACT

Since its outbreak in Wuhan, Hubei Province China, 2019-coronavirus infected disease (COVID-19) had been widely spread all over the world, the control of which calls for a better understanding of its epidemiology and clinical characteristics. We included 12 confirmed cases of COVID-19 in First Affiliated Hospital of Jilin University from 23 January 2020 to 11 February 2020, which were retrospectively analyzed for epidemiological, demographic, clinical, laboratory, and radiological features. All the patients were confirmed by nucleic acid detection, the average age of whom was 45.25 years (range, 23–79 years). Most patients had a history of Wuhan traveling or had contact with Wuhan travelers or infected cases. Obvious family cluster was observed. Clinical manifestations included fever (12/12), fatigue (10/12), cough (6/12), sore throat (4/12), headache (3/12), and diarrhea (2/12). Only three out of eight patients had pneumonia manifestation on radiography. Most patients had a normal white blood cell (WBC) count and normal or reduced lymphocyte (LY) count. Pneumonia changes were observed in all the four patients who underwent a chest CT scan. Only one elderly patient developed severe pneumonia, while all the rest were mild disease and had a self-limiting course.

KEYWORDS:

• COVID-19
• severe acute respiratory syndrome
• SARS-CoV-2
• clinical characteristic
• epidemiology
• Jilin

Introduction

Since the outbreak of a novel coronavirus pneumonia in Wuhan, Hubei Province China in December 2019, the disease has rapidly spread to many cities within China and globally [1,2]. The cause is the novel coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2; formerly known as 2019-nCoV) [3], and it is capable of rapid human-to-human transmission. The World Health Organization (WHO) has termed the pneumonia caused by SARS-CoV-2 as 2019-coronavirus infected disease (COVID-19) [3,4]. COVID-19 is believed to be a zoonotic disease that originated from Huanan Seafood Wholesale Market, although the intermediate host remains a puzzle [5]. The main routes include air, respiratory droplet, contact, and even fecal-oral route [6].

The number of suspected or confirmed cases and mortalities due to COVID-19 has continued to rise in Wuhan as well as in many other areas [7]. By 16 February 2020, Jilin Province had reported 89 cases confirmed by nucleic acid detection, among which 12 were diagnosed at First Affiliated Hospital of Jilin University.

There are still few reports regarding COVID-19 outside Wuhan. This article describes the epidemiology and clinical features of 12 cases of COVID-19 treated at the First Affiliated Hospital of Jilin University in Changchun City, Jilin Province.

Methods

From 23 January 2020 to 11 February 2020, we collected throat swabs from 109 outpatients suspected of SARS-CoV-2 infection and sent the swabs to the Disease Prevention and Control Center of Jilin Province for nucleic acid detection. Among these, 12 patients were reported as positive and were admitted to the Infection Department of First Affiliated Hospital of Jilin University. All the admitted patients underwent blood routine examination and lung computed tomography (CT); some underwent and chest radiography. Epidemiological, demographic, clinical, laboratory, radiological, and treatment data were collected.

The study was approved by the Ethics Committee of First Affiliated Hospital of Jilin University.

Results

The median age of the 12 hospitalized patients was 45.25 years (range, 23–79 years). Seven (54.3%) were men. Most of the patients had a history of traveling to Wuhan (patient [PT] 1 and PT 10) or to people who had traveled to Wuhan (PTs 2–7), or to patients with confirmed infections (PT 11, PT 12). The exposure history of two patients was unknown (PT 8 and PT 9). Epidemiological familial cluster was observed among these patients (Figure 1).

Figure 1. Epidemiological features of familial cluster

On admission, all 12 patients presented with fever (37.3–39.4°C) of 3 to 7 days. Other symptoms included fatigue, cough, sore throat, headache, and diarrhea in 10, 6, 4, 3, and 2 patients, respectively. Blood routine test was performed for all patients on admission. Most patients had a normal white blood cell (WBC) count and normal or reduced lymphocyte (LY) count (Table 1).

Table 1. Blood routine results of PTs 1 through 12

	WBC	LY	HGB	RBC	PLT
1	5.67	1.43	127	3.97	235
2	4.32	0.46↓ *	135	4.34	197
3	6.87	1.20↓ *	143	4.03	187
4	7.43	1.67	156	4.56	156
5	4.17	1.29	121	4.53	183
6	4.23	1.34	156	4.32	128
7	3.98	1.22	137	3.89	207
8	6.46	1.56	129	3.87	267
9	7.45	1.35	126	4.68	189
10	5.76	1.32	158	3.59	166
11	4.09	1.15	148	3.77	154
12	4.36	1.54	139	3.65	148

* ↓ indicates lower than the normal range.

HGB, hemoglobin concentration; LY, lymphocyte; PLT, platelet count; RBC, red blood cell count; WBC, white blood cell count.

On admission, chest x-ray was performed for eight patients. Three patients had typical viral pneumonia manifestations, such as multiple mottling and decrease of brightness (Figure 2), while no obvious abnormal change was observed on the radiography of the remaining five patients. Non-contrast enhanced chest CT scan was performed for the remaining four patients, on which typical changes of viral pneumonia, such as ground-glass opacity, were observed (Figure 3).

Figure 2. Typical change on chest radiographs of PT 10. The brightness of both lungs was decreased. Multiple patchy shadows with blurred edges were observed

Figure 3. Typical changes in non-contrast enhanced chest CT scan. Multiple peripheral patchy ground-glass opacities with obscure boundary were seen in bilateral multiple lobes. Condensation shadow was observed on the lower right lobe

Oxygen therapy was administrated to three patients, including one in severe condition (PT 2) who required high-flow nasal cannula oxygen therapy (oxygen flow 40 L/min, oxygen concentration 40%), and the blood oxygen saturation of the patient was maintained at 99%. None of the 12 patients required ventilation support. Five patients only had mild disease, the course of which was self-limited. Glucocorticoid (40 mg, intravenous infusion twice a day) was only administrated to the patient with severe disease (PT 2).

Discussion

The outbreak of the novel coronavirus SARS-CoV-2 has been declared by WHO as a public health emergency of international concern [1]. In view of its rapid spread, a better understanding of the epidemiology and clinical features of the disease is especially important, to aid early recognition and better containment. In the present study, most patients had a direct or indirect epidemiologic association with Wuhan, i.e. the patient had either returned from Wuhan or had been in contact with a confirmed patient who had returned from Wuhan. It is noteworthy that people are not necessarily infected by people who are obviously showing signs of the illness, but also by non-symptomatic carriers of the virus [8]. Thus, the pre-symptomatic transmission is a concern. Family aggregation is another epidemiologic feature observed in the present study. All these findings are consistent with other recent reports and indicate that COVID-19 is a highly contagious disease, the control of which requires early identification and strict quarantine [9–11].

Most of our patients developed only a mild disease with a self-limited disease course. Of the 12 patients observed in this study, only one elderly patient developed severe disease, which may be associated with existing underlying diseases and poor immunity. Consistent with the published findings, most patients had a normal WBC count and normal or reduced lymphocyte (LY) count [12]. It is worth mention that the patient with severe disease had a significantly low LY count, suggesting that lymphocyte reduction may correlate with disease severity.

SARS-CoV-2 infection was confirmed in all the patients via nucleic acid detection, but not all the patients showed a positive finding on radiography. Thus, chest x-ray may not be sensitive enough for identifying potential patients. On the other hand, all the patients underwent a chest CT scan and had a typical imaging finding of pneumonia. A recent study also reported that CT scan has a high sensitivity for the diagnosis of COVID-19 and can work as an auxiliary or even primary tool for COVID-19 detection when nucleic acid testing is not available [13].

SARS-CoV-2 is closely related to the SARS virus. They both belong to the genus human coronavirus (hCoV), which comprises both low- and high-pathogenic species. While a low-pathogenic coronavirus only infects the upper respiratory tract and causes mild, cold-like respiratory disease, highly pathogenic hCoVs such as SARS-CoV and Middle Eastern respiratory syndrome coronavirus (MERS-CoV) mainly infect the lower respiratory tract and can be fatal. Severe pneumonia induced by pathogenic hCoV is usually accompanied by rapid virus replication, massive inflammatory cell infiltration, and an elevated proinflammatory cytokine/chemokine response, leading to acute lung injury and respiratory distress syndrome. Therefore, during the rapid progression of the disease, glucocorticoid treatment can inhibit the overwhelmed inflammatory response and reduce damage to the lungs; this has been proved valid in the treatment of SARS [14].

Because of immune suppression, treatment with a steroid in MERS can result in delayed viral clearance and increased mortality and influenza infection [15]. A recent study reported that clinical evidence does not support corticosteroid treatment for lung injury due to SARS-CoV-2 [16]. Of the 12 patients in the present study, only one with severe disease was treated with steroids. In this patient, the pulmonary lesion was still not absorbed by the fifteenth day, and the pharynx remained positive for the nucleic acid throughout the course of the disease for 22 days. It seems that steroid treatments were not of significant benefit for this patient. Therefore, caution should be taken when considering corticosteroid administration in the treatment of COVID-19 pneumonia.

Acknowledgment of Funding

None.

Data availability statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Disclosure statement

No potential conflict of interest was reported by the authors.